Please click on the ID to see detailed information about each entry.
The total number entries retrieved from this search areID1089 | Sequence(GSGAGA)n | NameSilk fibroin peptide (3,000 Da) | Nature of peptide or cargoAnti-inflammatory | AssayHistochemical analysis | Tissue permeabilitySignificant permeability of the silk peptide can be seen in histochemical images | Tissue SampleEar of mice | PUBMED ID22189681 |
ID1090 | Sequence(GSGAGA)n | NameSilk fibroin peptide (3,000 Da) | Nature of peptide or cargoAnti-inflammatory | AssayRT-PCR, Western blotting | Tissue permeabilitySignificant decrease in translation of COX-2, IL-6 and IL-1β in presence of silk peptide +Tat-SOD can be seen in western blot images | Tissue SampleHaCaT keratinocytes | PUBMED ID22189681 |
ID1254 | SequenceVTHRLAGLLSRSGGM VKSNFVPTNVGSKAF | NameCGRP receptor antagonist CGRP(8-37) | Nature of peptide or cargoRegulation of blood flow, modulation of inflammation, and tissue remodelling | AssayPhotographed both hind paws using a micro-computer imaging device(MCID)-assessed analysis system. Immunostaining. Mann-Whitney U-test. | Tissue permeabilityEffect of the CGRP-receptor antagonist CGRP(8-37)(~24.5 mm2) on the necrotic area in UV-damaged skin of the rat hindpaw compared to solvent applications(~36.5 mm2). | Tissue SampleThe dorsum of both hind paws were irradiated of male Sprague-Dawley (SD) rats. | PUBMED ID8584255 |
ID1255 | SequenceVTHRLAGLLSRSGGM VKSNFVPTNVGSKAF | NameCGRP receptor antagonist CGRP(8-37) | Nature of peptide or cargoRegulation of blood flow, modulation of inflammation, and tissue remodelling | AssayPhotographed both hind paws using a micro-computer imaging device(MCID)-assessed analysis system. Immunostaining. Mann-Whitney U-test. | Tissue permeabilityEffect of the CGRP-receptor antagonist CGRP(8-37)(~17 mm2) on the necrotic area in UV-damaged skin of the rat hindpaw compared to solvent applications(~25 mm2). | Tissue SampleThe dorsum of both hind paws were irradiated of male Sprague-Dawley (SD) rats. | PUBMED ID8584255 |
ID1256 | SequenceVTHRLAGLLSRSGGM VKSNFVPTNVGSKAF | NameCGRP receptor antagonist CGRP(8-37) | Nature of peptide or cargoRegulation of blood flow, modulation of inflammation, and tissue remodelling | AssayPhotographed both hind paws using a micro-computer imaging device(MCID)-assessed analysis system. Immunostaining. Mann-Whitney U-test. | Tissue permeabilityEffect of the CGRP-receptor antagonist CGRP(8-37)(~13 mm2) on the necrotic area in UV-damaged skin of the rat hindpaw compared to solvent applications(~16.5 mm2). | Tissue SampleThe dorsum of both hind paws were irradiated of male Sprague-Dawley (SD) rats. | PUBMED ID8584255 |
ID1257 | SequenceVTHRLAGLLSRSGGM VKSNFVPTNVGSKAF | NameCGRP receptor antagonist CGRP(8-37) | Nature of peptide or cargoRegulation of blood flow, modulation of inflammation, and tissue remodelling | AssayPhotographed both hind paws using a micro-computer imaging device(MCID)-assessed analysis system. Immunostaining. Mann-Whitney U-test. | Tissue permeabilityEffect of the CGRP-receptor antagonist CGRP(8-37)(~12 mm2) on the necrotic area in UV-damaged skin of the rat hindpaw compared to solvent applications(~14 mm2). | Tissue SampleThe dorsum of both hind paws were irradiated of male Sprague-Dawley (SD) rats. | PUBMED ID8584255 |
ID1258 | SequenceVTHRLAGLLSRSGGM VKSNFVPTNVGSKAF | NameCGRP receptor antagonist CGRP(8-37) | Nature of peptide or cargoRegulation of blood flow, modulation of inflammation, and tissue remodelling | AssayPhotographed both hind paws using a micro-computer imaging device(MCID)-assessed analysis system. Immunostaining. Mann-Whitney U-test. | Tissue permeabilityEffect of the CGRP-receptor antagonist CGRP(8-37)(~7 mm2) on the necrotic area in UV-damaged skin of the rat hindpaw compared to solvent applications(~13.5 mm2). | Tissue SampleThe dorsum of both hind paws were irradiated of male Sprague-Dawley (SD) rats. | PUBMED ID8584255 |
ID1267 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of number of cups | Tissue permeabilityMeasurement of number of cups: Control:1.5 , Test:3 | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1268 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of number of cups | Tissue permeabilityMeasurement of number of cups: Control:4 , Test:9 | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1269 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of number of cups | Tissue permeabilityMeasurement of number of cups: Control:4.5 , Test:7.5 | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1270 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of number of cups | Tissue permeabilityMeasurement of number of cups: Control:7 , Test:15 | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1271 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of E2(Erection) | Tissue permeabilityMeasurement of E2(Erection): Control:15 , Test:26 | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1272 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of E2(Erection) | Tissue permeabilityMeasurement of E2(Erection): Control:4 , Test:11 | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1273 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of E2(Erection) | Tissue permeabilityMeasurement of E2(Erection): Control:6 , Test:12 | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1274 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of E2(Erection) | Tissue permeabilityMeasurement of E2(Erection): Control:11 , Test:24 | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1275 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first cup | Tissue permeabilityMeasurement of latency of first cup: Control:44 minutes , Test:38 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1276 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first cup | Tissue permeabilityMeasurement of latency of first cup: Control:25.5 minutes , Test:19 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1277 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first cup | Tissue permeabilityMeasurement of latency of first cup: Control:39 minutes , Test:32 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1278 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first cup | Tissue permeabilityMeasurement of latency of first cup: Control:23 minutes , Test:15 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1279 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first E2(Erection) | Tissue permeabilityMeasurement of latency of first E2(Erection): Control:29 minutes , Test:31 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1280 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first E2(Erection) | Tissue permeabilityMeasurement of latency of first E2(Erection): Control:32 minutes , Test:16 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1281 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first E2(Erection) | Tissue permeabilityMeasurement of latency of first E2(Erection): Control:9 minutes , Test:3 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1282 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first E2(Erection) | Tissue permeabilityMeasurement of latency of first E2(Erection): Control:3.5 minutes , Test:2 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1283 | SequenceHSDAVFTDNYTRLR KQ-Nle-AVKKYLNSILN | NameStearyl-Nle17- VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of number of cups | Tissue permeabilityMeasurement of number of first cup: Control:7 minutes , Test:20.2 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1284 | SequenceHSDAVFTDNYTRLR KQ-Nle-AVKKYLNSILN | NameStearyl-Nle17- VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of E2(Erection) | Tissue permeabilityMeasurement of number of first E2(Erection): Control:11 minutes , Test:35 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1285 | SequenceHSDAVFTDNYTRLR KQ-Nle-AVKKYLNSILN | NameStearyl-Nle17- VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first cup | Tissue permeabilityMeasurement of latency of first cup: Control:23 minutes , Test:10 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1286 | SequenceHSDAVFTDNYTRLR KQ-Nle-AVKKYLNSILN | NameStearyl-Nle17- VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay, Measurement of latency of first E2(Erection) | Tissue permeabilityMeasurement of latency of first E2(Erection): Control:3.5 minutes , Test:1.9 minutes | Tissue SampleIn castrated testosterone treated rats | PUBMED ID8156912 |
ID1287 | SequenceHSDAVFTDNYTRLR KQ-Nle-AVKKYLNSILN | NameStearyl-Nle17- VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay | Tissue permeabilityTime course of distribution of radioactively labelled peptide: Control:6 minutes , Test:20 minutes | Tissue SampleThree-month-old diabetic rats | PUBMED ID8156912 |
ID1288 | SequenceHSDAVFTDNYTRLR KQ-Nle-AVKKYLNSILN | NameStearyl-Nle17- VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadioactive assay | Tissue permeabilityTime course of distribution of radioactively labelled peptide:Control:5.5 minutes , Test:21.5 minutes | Tissue SampleSpontaneous high blood pressure rats(SHR) | PUBMED ID8156912 |
ID1348 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameVasoactive intestinal peptide (VIP) | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. | AssayLabelled peptide was detected and quantified by measuring radioactivity in a gamma counter | Tissue permeability0.6% of the applied material was found in the penile tissue | Tissue SampleRats with reduced sexual potential due to castration were employed for topical application on their penile organ. | PUBMED ID1522236 |
ID1349 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayLabelled peptide was detected and quantified by measuring radioactivity in a gamma counter | Tissue permeability5% of the applied material was found in the penile tissue | Tissue SampleRats with reduced sexual potential due to castration were employed for topical application on their penile organ. | PUBMED ID1522236 |
ID1350 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayLabelled peptide was detected and quantified by measuring radioactivity in a gamma counter | Tissue permeability2.5% of the applied material was found in the penile tissue | Tissue SampleRats with reduced sexual potential due to castration were employed for topical application on their penile organ. | PUBMED ID1522236 |
ID1351 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayLabelled peptide was detected and quantified by measuring radioactivity in a gamma counter | Tissue permeability1.25% of the applied material was found in the penile tissue | Tissue SampleRats with reduced sexual potential due to castration were employed for topical application on their penile organ. | PUBMED ID1522236 |
ID1352 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadiolabelling assay is used to determine incorporation per 10 ml blood as a percentage of the total radioactivity applied using gamma counter. | Tissue permeabilityApproximately 0.6% incorporation per 10 ml blood as a percentage of the total radioactivity applied | Tissue SampleRats with reduced sexual potential due to castration were employed for topical application on their penile organ to check sytemic dispersion. | PUBMED ID1522236 |
ID1353 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadiolabelling assay is used to determine incorporation per 10 ml blood as a percentage of the total radioactivity applied using gamma counter. | Tissue permeabilityApproximately 0.55% incorporation per 10 ml blood as a percentage of the total radioactivity applied | Tissue SampleRats with reduced sexual potential due to castration were employed for topical application on their penile organ to check sytemic dispersion. | PUBMED ID1522236 |
ID1354 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameStearyl-VIP | Nature of peptide or cargoA key penile neurotransmitter, induces erection after local injection in man. Significantly increased sexual function as measured by copulatory activity and penile reflexes(erections) in testosterone-treated, castrated rats. | AssayRadiolabelling assay is used to determine incorporation per 10 ml blood as a percentage of the total radioactivity applied using gamma counter. | Tissue permeabilityApproximately 0.4% incorporation per 10 ml blood as a percentage of the total radioactivity applied | Tissue SampleRats with reduced sexual potential due to castration were employed for topical application on their penile organ to check sytemic dispersion. | PUBMED ID1522236 |
ID1380 | SequenceSKYALVDASLKMSDP NRFRGKDLPVLDQL | NameHSV-1 gD 1-29 (group1) | Nature of peptide or cargoIntranasal aministration of HSV-gD peptides plus CpG can induce local ocular mucosal and systemic T-cell responses | AssayFACS | Tissue permeabilityDetectable HSV-1-specific CD4+ T cell responses were induced at the local (conjunctiva) and systemic (spleen) levels. | Tissue SampleNasal cavity of New Zealand White rabbits | PUBMED ID20089796 |
ID1383 | SequenceAPQIVRGASEDVRK QPYNLTIAWFRMGG | NameHSV-1 gD 77-104 (group-1) | Nature of peptide or cargoIntranasal aministration of HSV-gD peptides plus CpG can induce local ocular mucosal and systemic T-cell responses | AssayFACS | Tissue permeabilityDetectable HSV-1-specific CD4+ T cell responses were induced at the local (conjunctiva) and systemic (spleen) levels. | Tissue SampleNasal cavity of New Zealand White rabbits | PUBMED ID20089796 |
ID1384 | SequenceTIAWFRMGGNCAIP ITVMEYTECSYNKS | NameHSV-1 gD 96-123 (group 3) | Nature of peptide or cargoIntranasal aministration of HSV-gD peptides plus CpG can induce local ocular mucosal and systemic T-cell responses | AssayFACS | Tissue permeabilityDetectable HSV-1-specific CD4+ T cell responses were induced at the local (conjunctiva) and systemic (spleen) levels | Tissue SampleNasal cavity of New Zealand White rabbits | PUBMED ID20089796 |
ID1389 | SequenceQRTVAVYSLKIAGWH GPKAPYTSTLLPPEL | NameHSV-1 gD 228-257(group-3) | Nature of peptide or cargoIntranasal aministration of HSV-gD peptides plus CpG can induce local ocular mucosal and systemic T-cell responses | AssayFACS | Tissue permeabilityDetectable HSV-1-specific CD4+ T cell responses were induced at the local (conjunctiva) and systemic (spleen) levels | Tissue SampleNasal cavity of New Zealand White rabbits | PUBMED ID20089796 |
ID1390 | SequenceICGIVYWMRRHTQKA PKRIRLPHIRED | NameHSV-1 gD 332-358 (group-3) | Nature of peptide or cargoIntranasal aministration of HSV-gD peptides plus CpG can induce local ocular mucosal and systemic T-cell responses | AssayFACS | Tissue permeabilityDetectable HSV-1-specific CD4+ T cell responses were induced at the local (conjunctiva) and systemic (spleen) levels | Tissue SampleNasal cavity of New Zealand White rabbits | PUBMED ID20089796 |
ID1425 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameVasoactive intestinal peptide (VIP) | Nature of peptide or cargoPotent cAMP-dependent stimulus of both fluid and protein secretion from the rat and rabbit main lacrimal gland | AssayTear film osmolarity | Tissue permeabilityOsmolarity measurements: t=0 min., VIP/Buffer=330/314.5mOsm/l; t=16 min., VIP/Buffer=315/313.5mOsm/l | Tissue SampleEyes of male and female New Zealand white rabbits with closed lacrimal gland excretory duct | PUBMED ID2365569 |
ID1426 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameVasoactive intestinal peptide (VIP) | Nature of peptide or cargoPotent cAMP-dependent stimulus of both fluid and protein secretion from the rat and rabbit main lacrimal gland | AssayTear film osmolarity | Tissue permeabilityOsmolarity measurements: t=0 min., VIP/Buffer=320/318mOsm/l; t=6 min., VIP/Buffer=303.5/310mOsm/l; t=16 min., VIP/Buffer=310/314mOsm/l | Tissue SampleEyes of male and female New Zealand white rabbits with closed lacrimal gland excretory duct | PUBMED ID2365569 |
ID1427 | SequenceHSDAVFTDNYTRLR KQMAVKKYLNSILN | NameVasoactive intestinal peptide (VIP) | Nature of peptide or cargoPotent cAMP-dependent stimulus of both fluid and protein secretion from the rat and rabbit main lacrimal gland | AssayOsmolarity and tear volume measurements | Tissue permeabilityOsmolarity measurements: t=0 min., VIP/Buffer=315/320mOsm/l; t=6 min., VIP/Buffer=301/314mOsm/l; t=16 min., VIP/Buffer=308/313mOsm/l; Volume measurement: VIP/Buffer= 17µl/7µl | Tissue SampleEyes of male and female New Zealand white rabbits with closed lacrimal gland excretory duct | PUBMED ID2365569 |
ID1428 | SequenceHSDGTLTSELSRLRD RARLQRLLQGLL | NameSecretin | Nature of peptide or cargoSecretin stimulates the release of a watery bicarbonate solution from the pancreatic and bile duct epithelium. | AssayTear film osmolarity | Tissue permeabilityCaused decrease in tear film osmolarity | Tissue SampleEyes of male and female New Zealand white rabbits with closed lacrimal gland excretory duct | PUBMED ID2365569 |
ID1429 | SequenceHSDGTLTSELSRLRD RARLQRLLQGLL | NameSecretin | Nature of peptide or cargoSecretin stimulates the release of a watery bicarbonate solution from the pancreatic and bile duct epithelium. | AssayTear film osmolarity | Tissue permeabilityCaused decrease in tear film osmolarity | Tissue SampleEyes of male and female New Zealand white rabbits with closed lacrimal gland excretory duct | PUBMED ID2365569 |
ID1430 | SequenceHSDGTLTSELSRLRD RARLQRLLQGLL | NameSecretin | Nature of peptide or cargoSecretin stimulates the release of a watery bicarbonate solution from the pancreatic and bile duct epithelium. | AssayOsmolarity and tear volume measurements | Tissue permeabilityCaused decrease in tear film osmolarity, Tear volume: VIP/Buffer= 5.0±0.8µl/5.5±0.5µl | Tissue SampleEyes of male and female New Zealand white rabbits with closed lacrimal gland excretory duct | PUBMED ID2365569 |
ID1431 | SequenceHSQGTFTSDYSKYLD SRRAQDFVQWLMNT | NameGlucagon | Nature of peptide or cargoThe pancreas releases glucagon when the concentration of glucose in the bloodstream falls too low in order to raise glucose levels | AssayTear film osmolarity | Tissue permeabilityOsmolarity measurements: t=0 min., Glucagon/Buffer=311/312.5mOsm/l; t=6 min., Glucagon/Buffer=304/306.5mOsm/l; t=16 min., Glucagon/Buffer=305/307.5mOsm/l | Tissue SampleEyes of male and female New Zealand white rabbits with closed lacrimal gland excretory duct | PUBMED ID2365569 |
ID1432 | SequenceHSQGTFTSDYSKYLD SRRAQDFVQWLMNT | NameGlucagon | Nature of peptide or cargoThe pancreas releases glucagon when the concentration of glucose in the bloodstream falls too low in order to raise glucose levels | AssayOsmolarity and tear volume measurements | Tissue permeabilityOsmolarity measurements: t=0 min., Glucagon/Buffer=310/308mOsm/l; t=6 min., Glucagon/Buffer=301/306mOsm/l; t=16 min., Glucagon/Buffer=305/307mOsm/l; Volume measurement: Glucagon/Buffer= 11.5µl/5.2µl | Tissue SampleEyes of male and female New Zealand white rabbits with closed lacrimal gland excretory duct | PUBMED ID2365569 |
ID1503 | SequenceSKYALVDASLKMADP NRFRGKDLPVLDQL | NamegD 1-29 (group 1) | Nature of peptide or cargonot mentioned | AssayELISA, Antibody assay, Peptide specific T-cell assays | Tissue permeabilityFailed to induce significant IgA titers (p > 1). | Tissue Sampleeye | PUBMED ID15603887 |